Mission Bio Launches First Automated Custom Panel Designer for Mouse Genomes and CRISPR Editing to Accelerate Breakthroughs in Cancer Research
Renaissance BioScience Corp. to receive R&D funding to advance its yeast-based RNAi biopesticide and biotherapeutics technology
Enzymicals and Syngulon sign a non-exclusive license agreement on the use of Syngulon’s antibiotic free technology to produce enzymes
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies
